Sarcoidosis causes abnormal seasonal variation in 1,25-dihydroxy-cholecalciferol

Journal of Internal Medicine

Volumn 239, Issue 5, 1996, Pages 393-398

  Bonnema, S J ^a,b   Moller J ^a   Marving, J ^a   Kvetny, J ^a  

^a Esbjerg Centralsygehus   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Bone scintigraphy; Calcitriols; Parathyroid hormone; Sarcoidosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; MARKER; PARATHYROID HORMONE;

ADULT; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SARCOIDOSIS; SEASONAL VARIATION;

EID: 0030055040     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.472813000.x     Document Type: Article

References (23)

1. 3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985; 60: 960-66.
2. James DG, Williams WG. Biochemistry. In: Smith LH, ed. Sarcoidosis and Other Granuloinatous Disorders. Philadelphia: W. B. Saunders Company. 1985: 163-73.
3. Chesney RW, Rosen JF, Hamstra AJ, Smith C, Mahaffey K, DeLuca HF. Absence of seasonal variation in serum concentrations of 1.25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J Clin Endocrinol Metab 1981; 53: 139-42.
4. Tjellesen L, Christiansen C. Vitamin D metabolites in normal subjects during one year. A longitudinal study. Scand J Clin Lab Invest 1983; 43: 85-9.
5. 3. Scand J Clin Lab Invest 1986; 46: 723-9.
6. Juttmann JR, Visser TJ, Buurman C, de Kam E, Birkenhäger JC. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J 1981; 282: 1349-52.
7. Vanderschueren D, Gevers G, Dequeker J, Geusens P, Nijs J, Devos P et al. Seasonal variation in bone metabolism in young healthy subjects. Calcif Tissue Int 1991; 49: 84-9.
8. Taylor AF, Norman ME. Vitamin D metabolite levels in normal children. Padiatr Res 1984; 18: 886-90.
9. Adams JS, Gacad MA, Anders A, Endres DB, Sharma OM. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis. Sarcoidosis 1986: 3: 1-6.
10. Koide Y, Kugai N, Kimura S, Fujita T, Yamashita N, Hiramoto T et al. Increased 1,25-dihydroxy-cholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis. J Clin Endocrinol Metab 1981; 52: 494-8.
11. 3. Q J Med 1984; 53: 165-80.
12. 3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985; 161: 755-65.
13. Bell NH, Gill JR, Bartter FC. On the abnormal calcium absorbtion in sarcoidosis: evidence for increased sensitivity to vitamin D. Am J Med 1964; 36: 500-13.
14. Bell NH, Stern PH, Pantzer E, Sinha TK, Deluca HF. Evidence that increased circulating 1-alfa,25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 1979; 64: 218-25.
15. Stern PH, de Olazabal J, Bell NH. Evidence for abnormal regulation of circulating 1,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest 1989; 66: 852-5.
16. Papapoulous SE, Fraher LJ, Sandier LM, Clemens TL, Lewin IG, O'Riordan JLH. 1.25-dihydroxy-cholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1979; i: 627-30.
17. Fuss M, Bergans A, Gillet C, Karmali R, Pepersack T, Bagon JA et al. Calcium metabolism disturbances in sarcoidosis. Acta Clin Belg 1987; 42: 421-30.
18. Franck H, Hehrmann R, Keck E, Krüskemper HL. Increased parathyroid hormone in a patient with sarcoidosis and hypercalcaemia. Klin Wochenschr 1987; 65: 737.
19. Chose RR, Brown RC, Woodhead JS. Incomplete suppression of parathyroid hormone activity in sarcoidosis presenting with hypercalcaemia. Postgrad Med J 1983; 59: 572-4.
20. Fogelman I, Bessent R, Scullion JE, Cuthbert GF. Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements. Eur J Nucl Med 1982; 7: 359-63.
21. Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR. The use of whole-body retention of Tc99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 1978; 19: 270-75.
22. Fogelman I, McKillop JH, Cowden EA, Fine A, Boyce B, Boyle IT, Greig WR. Bone scan findings in hypervitaminosis D: case report. J Nucl Med 1977; 18: 1205-7.
23. Fogelman I, Pearson DW, Bessent RG, Tofe AJ, Francis MD. A comparison of skeletal uptake of three diphosphonates by whole-body retention: concise communication. J Nucl Med 1981; 22: 880-83.